SecSonar.com

GeoVax Labs, Inc. (GOVX)

GeoVax Labs, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

GeoVax Labs, Inc. (GOVX) is a Biotechnology company based in US with a market capitalization of $2M. Free cash flow was negative at -$21.5M. This page tracks GOVX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 17 employees · IPO Sep 25, 2020

Valuation

Valuation & price

$1.23 · as of May 17, 2026 · -94.2% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

0.00

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$21.27$11.18$1.09Jul 25Dec 25Jul 26Jul 7, 25$12.56Jul 9, 25$16.35Jul 11, 25$16.89Jul 15, 25$17.25Jul 17, 25$18.26Jul 21, 25$20.50Jul 23, 25$21.27Jul 25, 25$19.75Jul 29, 25$18.79Jul 31, 25$18.01Aug 4, 25$19.40Aug 6, 25$16.52Aug 11, 25$17.00Aug 13, 25$18.48Aug 15, 25$18.99Aug 19, 25$17.67Aug 21, 25$18.75Aug 25, 25$18.92Aug 27, 25$18.94Aug 29, 25$18.64Sep 3, 25$18.67Sep 5, 25$17.44Sep 9, 25$17.23Sep 11, 25$17.91Sep 16, 25$17.43Sep 18, 25$16.54Sep 22, 25$16.42Sep 24, 25$16.25Sep 26, 25$16.15Sep 30, 25$11.83Oct 2, 25$13.88Oct 6, 25$14.37Oct 8, 25$14.57Oct 10, 25$13.89Oct 14, 25$15.11Oct 16, 25$14.05Oct 21, 25$14.47Oct 23, 25$13.50Oct 27, 25$14.31Oct 29, 25$13.81Oct 31, 25$14.14Nov 4, 25$13.60Nov 6, 25$13.02Nov 10, 25$12.52Nov 12, 25$12.45Nov 14, 25$11.28Nov 18, 25$10.20Nov 20, 25$10.03Nov 25, 25$9.48Nov 28, 25$10.28Dec 2, 25$9.30Dec 4, 25$9.59Dec 8, 25$10.31Dec 10, 25$9.90Dec 12, 25$9.37Dec 16, 25$7.16Dec 18, 25$6.00Dec 22, 25$4.31Dec 24, 25$4.54Dec 29, 25$4.26Jan 2, 26$5.18Jan 6, 26$5.44Jan 8, 26$4.62Jan 12, 26$3.57Jan 14, 26$2.86Jan 16, 26$2.99Jan 21, 26$2.98Jan 23, 26$3.15Jan 27, 26$2.84Jan 29, 26$2.83Feb 2, 26$2.80Feb 4, 26$2.82Feb 9, 26$2.66Feb 11, 26$2.55Feb 13, 26$1.68Feb 18, 26$1.39Feb 20, 26$1.53Feb 24, 26$1.60Feb 26, 26$1.60Mar 2, 26$1.56Mar 4, 26$1.71Mar 6, 26$1.79Mar 10, 26$1.93Mar 12, 26$1.86Mar 17, 26$1.68Mar 19, 26$1.43Mar 23, 26$1.50Mar 25, 26$1.50Mar 27, 26$1.40Mar 31, 26$1.38Apr 2, 26$1.33Apr 7, 26$1.21Apr 9, 26$1.16Apr 13, 26$1.28Apr 15, 26$1.28Apr 17, 26$1.24Apr 22, 26$1.17Apr 24, 26$1.09Apr 28, 26$1.10Apr 30, 26$1.09May 4, 26$1.27May 6, 26$1.65May 8, 26$1.67May 12, 26$1.37May 14, 26$1.26May 18, 26$2.21May 20, 26$2.23May 22, 26$3.64May 28, 26$2.40Jun 1, 26$2.21Jun 3, 26$2.03Jun 5, 26$1.65Jun 9, 26$1.28Jun 11, 26$1.18Jun 15, 26$1.18Jun 17, 26$1.18Jun 22, 26$1.32Jun 24, 26$1.38Jun 26, 26$1.32Jul 2, 26$1.27
$1.0552-week range$21.27
Loading valuation history…

Fundamentals

Key fundamentals

$2M

Market cap

—

Revenue growth (YoY)

100.0%

Gross margin

-$21.5M

Free cash flow (USD)

-$2.2T

Net debt

Net cash position

361.9%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$828.9KFY 2017$1.1MFY 2018$963.0KFY 2019$1.2MFY 2020$1.8MFY 2021$385.5KFY 2022$81.5KFY 2023$0.00FY 2024$4.0MFY 2025$2.5M
$828.9K$2.5M

Free cash flow by year

2016 → 2025

FY 2016$-17.8MFY 2017$-1.7MFY 2018$-1.5MFY 2019$-1.4MFY 2020$-2.9MFY 2021$-11.2MFY 2022$-19.2MFY 2023$-25.2MFY 2024$-24.7MFY 2025$-21.5M
-$17.8M-$21.5M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022-11090.9%FY 202497.6%FY 2025100.0%
100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 14, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 17, 2026Filing
  • 8-K eventSecurities Purchase AgreementMay 19, 2026Filing
  • Quarterly report10-Q FiledMay 14, 2026Filing
  • 8-K eventEarnings ReleaseMay 14, 2026Filing
  • 8-K eventWarrant IssuanceMay 7, 2026Filing
  • Annual report10-K FiledApr 15, 2026Filing
  • 8-K eventEarnings ReleaseApr 15, 2026Filing

Questions

Frequently asked questions

What is GeoVax Labs, Inc.'s market cap?

GeoVax Labs, Inc. (GOVX) has a market capitalization of $2M.

What is GOVX's P/E ratio?

A meaningful P/E ratio is not available for GOVX — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is GOVX's price-to-book (P/B) ratio?

GOVX trades at 0.00 times book value per share.

Are insiders buying GOVX stock?

SEC Form 4 filings show no open-market insider buys at GeoVax Labs, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CANF

Can-Fite BioPharma Ltd.

$1.8M

AZTR

Azitra, Inc.

$2.3M

AIM

AIM ImmunoTech Inc.

$1.3M

ENSC

Ensysce Biosciences, Inc.

$2.6M

SXTP

60 Degrees Pharmaceuticals, Inc.

$1.2M

INM

InMed Pharmaceuticals Inc.

$2.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.